Document 0665
 DOCN  M95A0665
 TI    AZT and children. 
 DT    9510
 SO    Treat Rev. 1995 Mar/Apr;(no 17):2. Unique Identifier : AIDSLINE
       AIDS/95700318
 AB    The AZT part of a study (ACTG 152), examining three different treatments
       for children (aged 3 months to 18 years) with sympomatic HIV infection,
       was stopped because the interim results showed AZT alone was the least
       effective of the three treatments, and children taking AZT alone had
       higher rates of side effects. The groups of children taking ddI alone
       and ddI with AZT will be continued. Further analysis will be conducted
       in 1995 after the study ends.
 DE    Adolescence  Child  Child, Preschool  Didanosine/ADMINISTRATION &
       DOSAGE/THERAPEUTIC USE  Drug Therapy, Combination  HIV Infections/*DRUG
       THERAPY  Human  Infant  Zidovudine/ADMINISTRATION & DOSAGE/*THERAPEUTIC
       USE  NEWSLETTER ARTICLE  CLINICAL TRIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).